Veru’s stock nearly triples after oral COVID-19 treatment leads to ‘statistically meaningful’ reduction in deaths

Shares of Veru Inc. VERU, +182.30% rocketed 175% toward a 13-month high in afternoon trading Monday, after biopharmaceutical company announced positive results from its Phase 3 trial of its oral COVID...